Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Neubert, D. Ridder, P. Bargiotas, S. Akira, M. Schwaninger (2011)
Acute inhibition of TAK1 protects against neuronal death in cerebral ischemiaCell Death and Differentiation, 18
Tomohiro Mizuno, K. Ishikawa, W. Sato, Takahiro Koike, Mayu Kushida, Yasuhiro Miyagawa, Kiyofumi Yamada, S. Hirata, E. Imai, Y. Noda (2013)
The Risk Factors of Severe Acute Kidney Injury Induced by CisplatinOncology, 85
J. Ninomiya-Tsuji, Kazuya Kishimoto, Atsushi Hiyama, J. Inoue, Z. Cao, Kunihiro Matsumoto (1999)
The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathwayNature, 398
Hua Liang, Zhengmao Zhang, Liqun He, Yanlin Wang (2016)
CXCL16 regulates cisplatin-induced acute kidney injuryOncotarget, 7
Yong Pan, Yi Wang, Yunjie Zhao, Kesong Peng, Weixin Li, Yonggang Wang, Jingjing Zhang, Shanshan Zhou, Quan Liu, Xiaokun Li, L. Cai, G. Liang (2014)
Inhibition of JNK Phosphorylation by a Novel Curcumin Analog Prevents High Glucose–Induced Inflammation and Apoptosis in Cardiomyocytes and the Development of Diabetic CardiomyopathyDiabetes, 63
Emily Omori, Sho Morioka, Kunihiro Matsumoto, J. Ninomiya-Tsuji (2008)
TAK1 Regulates Reactive Oxygen Species and Cell Death in Keratinocytes, Which Is Essential for Skin Integrity*Journal of Biological Chemistry, 283
B. Zhang, G. Ramesh, C. Norbury, W. Reeves (2007)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.Kidney international, 72 1
G. Ramesh, W. Reeves (2004)
Inflammatory cytokines in acute renal failure.Kidney international. Supplement, 91
H. Jang, H. Rabb (2015)
Immune cells in experimental acute kidney injuryNature Reviews Nephrology, 11
Navjotsingh Pabla, Zheng Dong (2008)
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.Kidney international, 73 9
H. Sakurai (2012)
Targeting of TAK1 in inflammatory disorders and cancer.Trends in pharmacological sciences, 33 10
J. Delaney, M. Mlodzik (2006)
TGFβ Activated Kinase-1: New Insights into the Diverse Roles of TAK1 in Development and ImmunityCell Cycle, 5
A. Ajibade, Qinfu Wang, J. Cui, Jia Zou, X. Xia, Mingjun Wang, Y. Tong, W. Hui, Dou Liu, B. Su, Helen Wang, Rong-Fu Wang (2012)
TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils.Immunity, 36 1
M. Xie, Dou-xia Zhang, J. Dyck, Yi Li, Hui Zhang, M. Morishima, D. Mann, G. Taffet, A. Baldini, D. Khoury, M. Schneider (2006)
A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathwayProceedings of the National Academy of Sciences, 103
A. Ozkok, C. Edelstein (2014)
Pathophysiology of Cisplatin-Induced Acute Kidney InjuryBioMed Research International, 2014
E. Rankin, J. Tomaszewski, V. Haase (2006)
Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.Cancer research, 66 5
RW Schrier (2002)
Cancer therapy and renal injury, 110
Xiaogao Jin, Jiyuan Chen, Zhaoyong Hu, L. Chan, Yanlin Wang (2012)
Genetic deficiency of adiponectin protects against acute kidney injuryKidney international, 83
M. Perazella, G. Moeckel (2010)
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.Seminars in nephrology, 30 6
D. Bao, Dan Lu, Ning Liu, W. Dong, Yingdong Lu, Chuan Qin, Lianfeng Zhang (2015)
Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathwaysDisease Models & Mechanisms, 8
Giulia Benedetti, Lisa Fredriksson, B. Herpers, J. Meerman, B. Water, Marjo Graauw (2013)
TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.Biochemical pharmacology, 85 2
September Mihaly, J. Ninomiya-Tsuji, Sho Morioka, Sho Morioka (2014)
TAK1 control of cell deathCell Death and Differentiation, 21
Jun Zhou, Li Jia, Zhaoyong Hu, Yanlin Wang (2017)
Pharmacological Inhibition of PTEN Aggravates Acute Kidney InjuryScientific Reports, 7
DN Dhanasekaran, E. Reddy (2008)
JNK signaling in apoptosisOncogene, 27
N. Santos, M. Rodrigues, N. Martins, A. Santos (2012)
Cisplatin-induced nephrotoxicity and targets of nephroprotection: an updateArchives of Toxicology, 86
Shintaro Sato, H. Sanjo, K. Takeda, J. Ninomiya-Tsuji, Masahiro Yamamoto, T. Kawai, Kunihiro Matsumoto, O. Takeuchi, S. Akira (2005)
Essential function for the kinase TAK1 in innate and adaptive immune responsesNature Immunology, 6
Dingding Zhang, Huiying Yan, Hua Li, S. Hao, Zhuang Zong, M. Liu, Qing Sun, Yi-qing Yang, Mengliang Zhou, Kuanyu Li, C. Hang (2015)
TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage*The Journal of Biological Chemistry, 290
Yuka Ikeda, Sho Morioka, Kunihiro Matsumoto, J. Ninomiya-Tsuji (2014)
TAK1 Binding Protein 2 Is Essential for Liver Protection from StressorsPLoS ONE, 9
D. Lebwohl, R. Canetta (1998)
Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.European journal of cancer, 34 10
I Arany, RL Safirstein (2003)
Cisplatin nephrotoxicity, 23
L Li, Y Chen, J Doan, J Murray, JD Molkentin, Q Liu (2014)
Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling, 130
Y. Ip, R. Davis (1998)
Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.Current opinion in cell biology, 10 2
A. Havasi, S. Borkan (2011)
Apoptosis and acute kidney injury.Kidney international, 80 1
B. Cummings, R. Schnellmann (2002)
Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways.The Journal of pharmacology and experimental therapeutics, 302 1
G. Ramesh, W. Reeves (2002)
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicityJournal of Clinical Investigation, 110
Cisplatin can cause acute kidney injury (AKI), but the molecular mechanisms are not well understood. The objective of the present study was to examine the role of transforming growth factor-β-activated kinase-1 (TAK1) in the pathogenesis of cisplatin-induced AKI. Wild-type mice and proximal tubule TAK1-deficient mice were treated with vehicle or cisplatin. Compared with wild-type control mice, proximal tubule TAK1-deficient mice had less severe kidney dysfunction, tubular damage, and apoptosis after cisplatin–induced AKI. Furthermore, conditional disruption of TAK1 in proximal tubular epithelial cells reduced caspase-3 activation, proinflammatory molecule expression, and JNK phosphorylation in the kidney in cisplatin-induced AKI. Taken together, cisplatin activates TAK1-JNK signaling pathway to promote tubular epithelial cell apoptosis and inflammation in cisplatin-induced AKI. Targeting TAK1 could be a novel therapeutic strategy against cisplatin-induced AKI.
American Journal of Physiology-Renal Physiology – The American Physiological Society
Published: Jan 1, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.